Allergy & Autoimmune

NIAID Strategic Plan Details Covid-19 Research Priorities

Research is needed to improve our understanding of the virus and how it causes covid-19, and to develop strategies to mitigate illness and death.

FDA Covid-19 Update: Serological Test Validation and Education Efforts
BARDA Awards Contract for Rapid Coronavirus In-Home Self-Test
SARS-CoV-2 Coronavirus Stable for Hours on Surfaces
CLP Reader Survey: Clinical Lab Testing for Covid-19
COVID-19: FDA Gives Flexibility to New York State Department of Health, Issues Emergency Use Authorization for Roche Diagnostic
Study Demonstrates Clinical Utility and Accuracy of Panel Test for Patients with Symptoms of Autoimmune Encephalopathy
ACR Updates Recommendations for Rheumatoid Arthritis Disease Activity Measurement
NIAID Researchers Estimate 17% of Food-Allergic Children Have Sesame Allergy
Owlstone Medical Provides Breath Biopsy Analysis to Study of Immune-Mediated Diseases

Allergy & Autoimmune

Immunovia Launches Rheumatoid Arthritis Pipeline Project, Announces Research Collaboration

The company’s IMMray antibody array technology shows an accuracy greater than 90% when diagnosing CCP-negative rheumatoid arthritis patients.

Allergy & Autoimmune

PsoriasisDX Genetic Test for Psoriatic Arthritis Now Available In Europe

Molecular dermatology research and development innovator DermaGenoma Inc announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive.

United Rheumatology Adds Multibiomarker Blood Test to Clinical Guidelines

Jan 31, 2017 | Allergy & Autoimmune

The guidelines are designed to assist healthcare professionals in the diagnosis, treatment, and monitoring of patients with rheumatoid arthritis.

Environmental Trigger Test Evaluates Latent Pathogens

Dec 27, 2016 | Allergy & Autoimmune

The test assesses the immune load from 29 bacterial, fungal, parasitic, stealth, and viral organism antigens that may be latent in the body.

Tests Facilitate Autoimmune Thyroid Disease Management

Jul 11, 2016 | Allergy & Autoimmune

The tests quantitatively measure a patient’s autoantibodies to thyroglobulin or thyroid peroxidase, providing information that can help clinicians in the diagnosis of autoimmune thyroid disease.

Protagen Joins Global Consortium Examining Rheumatoid Arthritis

Mar 1, 2016 | Allergy & Autoimmune

The RA-MAP consortium aims to identify clinical, molecular and cellular biomarkers of prognosis and therapeutic response in patients with early RA.

FDA Clears Nut Allergen Component Tests

Feb 8, 2016 | Allergy & Autoimmune, Clinical Chemistry, Clinical Chemistry Test Kits

The allergen component tests by Thermo Fisher Scientific detect immunoglobulin E sensitization to hazelnut, walnut, and cashew nut proteins.

Allergies and Autoimmune Diseases

Aug 25, 2015 | Allergy & Autoimmune

The incidence of allergies and autoimmune diseases has been increasing over the past several decades, with both diseases rising to become a major women’s issue.

Rheumatoid Arthritis Blood Test Gains Expanded Use Indications

Aug 18, 2015 | Allergy & Autoimmune

In addition to assisting with early diagnosis, the test’s expanded indications support treat-to-target objectives by allowing close monitoring of 14-3-3η levels along the clinical management path to detect how active the joint damage processes are.

Immunovent’s Test Aims to Uncover Allergies That Current Allergy Tests Cannot

Jan 27, 2015 | Allergy & Autoimmune, Immunoassay, Immunoassay Reagents & test Kits

For Immunovent’s innovative approach to allergy diagnosis, MABA names the company the “best of the best” in its year-end first pitch life science competition.

European Deals Widen Availability of Blood Thinner Allergy Assay

Dec 30, 2014 | Allergy & Autoimmune, Coagulation Testing, Hematology & Serology

Akers Biosciences has entered into multiyear distribution agreements with Cryopep SARL and DiaLine AG for its PIFA Heparin and PF4 rapid assay products, which determine whether a patient being treated with the blood thinner heparin may be developing a drug allergy.

FDA Authorizes First Commercially Available Screening Test for Severe Combined Immunodeficiency

Dec 23, 2014 | Allergy & Autoimmune

The Victor EnLite and EnLite Neonatal TREC kit from PerkinElmer is the first commercially available screening test in the United States and Canada for severe combined immunodeficiency, known as “Bubble Boy” disease. Affecting an estimated 1 in 58,000 newborns each year, SCID is an inherited genetic condition that makes it extremely difficult to fight off infections.

Category: Allergy & Autoimmune

Allergy & Autoimmune

Allergy & Autoimmune

Allergy & Autoimmune